Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
180
-
Total shares
-
54.7M
-
Shares change
-
+1.28M
-
Total reported value, excl. options
-
$1.45B
-
Value change
-
+$34.7M
-
Put/Call ratio
-
0.75
-
Number of buys
-
99
-
Number of sells
-
-78
-
Price
-
$26.42
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q1 2014
187 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q1 2014.
IMPAX LABORATORIES INC - COM (IPXL) has 180 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.7M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5.35M shares), BlackRock Fund Advisors (4.95M shares), VANGUARD GROUP INC (4.4M shares), FMR LLC (4.22M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (2.3M shares), State Street Corp (2.09M shares), BlackRock Institutional Trust Company, N.A. (1.95M shares), Invesco Ltd. (1.66M shares), AMERIPRISE FINANCIAL INC (1.63M shares), and JENNISON ASSOCIATES LLC (1.41M shares).
This table shows the top 180 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.